Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring
Engstrom, Lars D
Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Nov 2017 - 6661-6672 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article
1557-3265
10.1158/1078-0432.CCR-17-1192 doi
Adult
Aged
Animals
Antineoplastic Agents--pharmacology
Benzeneacetamides--pharmacology
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Line, Tumor
Crizotinib
Drug Resistance, Neoplasm--drug effects
Exons--genetics
Female
Humans
Liver Neoplasms--drug therapy
Male
Mice
Middle Aged
Mutation
Protein Kinase Inhibitors--administration & dosage
Proto-Oncogene Proteins c-met--antagonists & inhibitors
Pyrazoles--administration & dosage
Pyridines--administration & dosage
Xenograft Model Antitumor Assays
Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Nov 2017 - 6661-6672 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article
1557-3265
10.1158/1078-0432.CCR-17-1192 doi
Adult
Aged
Animals
Antineoplastic Agents--pharmacology
Benzeneacetamides--pharmacology
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Line, Tumor
Crizotinib
Drug Resistance, Neoplasm--drug effects
Exons--genetics
Female
Humans
Liver Neoplasms--drug therapy
Male
Mice
Middle Aged
Mutation
Protein Kinase Inhibitors--administration & dosage
Proto-Oncogene Proteins c-met--antagonists & inhibitors
Pyrazoles--administration & dosage
Pyridines--administration & dosage
Xenograft Model Antitumor Assays